insights_auto
Why is 000739 down ၇.၆၉%?
Dive Deeperchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
၂၁.၆၂ CN¥
arrow_downward
-၇.၆၉%(-၁.၈၀) 1D
အောက် ၁၉, GMT+၈ ၁၅:၀၄:၂၁ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
၂၃.၀၂ CN¥
High
၂၃.၅၇ CN¥
Low
၂၁.၀၈ CN¥
Mkt. cap
ဋေ ၂.၇၁ ထ
Avg. vol.
၁.၆၆ ကုဋေ
Volume
၃.၅၈ ကုဋေ
Dividend
၁.၇၄%
Quarterly dividend
၀.၀၉ CN¥
Ex-dividend date
၂၀၂၆ အောက် ၈
P/E ratio
၂၉.၃၄
52-wk high
၂၈.၅၀ CN¥
52-wk low
၁၄.၈၉ CN¥
EPS
၀.၇၄ CN¥
Shares outstanding
၁၁၅.၈၄ ဋေ
No. of employees
၇ ထောင်
Open
၂၃.၀၂ CN¥
High
၂၃.၅၇ CN¥
Low
၂၁.၀၈ CN¥
Mkt. cap
ဋေ ၂.၇၁ ထ
Avg. vol.
၁.၆၆ ကုဋေ
Volume
၃.၅၈ ကုဋေ
Dividend
၁.၇၄%
Quarterly dividend
၀.၀၉ CN¥
Ex-dividend date
၂၀၂၆ အောက် ၈
P/E ratio
၂၉.၃၄
52-wk high
၂၈.၅၀ CN¥
52-wk low
၁၄.၈၉ CN¥
EPS
၀.၇၄ CN¥
Shares outstanding
၁၁၅.၈၄ ဋေ
No. of employees
၇ ထောင်
News stories
From web sources and news partners
GlobeNewswire
·
ပြီးခဲ့သည့် ၂၆ မိနစ်
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
Nasdaq names Algoma Steel (NASDAQ: ASTL) warrants for removal from listing and/or registration.
TradingView
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
S&P 500, Nasdaq advance ahead of mega-cap companies’ earnings
CNBC
·
ပြီးခဲ့သည့် ၁၆ မိနစ်
The turnaround of this beaten-up Dow stock looks for real, says Katie Stockton
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd